TABLE 1

Best-fit-derived kinetic parameters for CP O-glucuronidation by HLM and baculovirus-expressed human UGT isoforms

Each value represents best-fit values ± S.D.

UGT Isoform1-O-CP Glucuronide Kinetics ± S.D. (n = 3)3-O-CP Glucuronide Kinetics ± S.D. (n = 3)
KmcVmaxcCLintcKm or S50eVmaxCLint1 or CLmaxbKmVmaxCLint2
μMpmol/min/mg proteinl/min/mg proteinμMpmol/min/mg proteinl/min/mg proteinμMpmol/min/mg proteinl/min/mg protein
Pooled HLMd408.2 ± 41.416.7 ± 0.60.04146.0 ± 27.0d37.9 ± 13.0d0.82d1027 ± 129.8d232 ± 11.2d0.226d
2B7115.0 ± 14.25.4 ± 0.20.047109.1 ± 5.246.9 ± 0.40.43a
1A6<LOQ1557.0 ± 122.1e12.9 ± 0.3e0.008b
1A9<LOQ714.4 ± 30.2e41.9 ± 0.6e0.059b
  • <LOQ, below limit of quantitation.

  • a CLint calculated from Michaelis-Menten kinetics.

  • b CLmax calculated from Hill equation fitted kinetics.

  • c Best-fit kinetic parameters for 1-O-CP glucuronide calculated with substrate inhibition equation Ksi (HLM) was 28500 ± 8200 μM and Ksi (UGT2B7) was 8090 ± 1240 μM.

  • d Best-fit Km1 and Km2 and Vmax1 and Vmax2 kinetic parameters calculated for 3-O-CP glucuronide with two-enzyme Michaelis-Menten equation.

  • e Best-fit kinetic parameters for 3-O-CP glucuronide calculated using Hill equation.